We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current ALGBE market cap is 15.07M. The company's latest EPS is EUR -0.4772 and P/E is -1.74.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 3.49M | 3.28M | 3.13M | 1.8M | 7.34M |
| Operating Income | -13.9M | -13.06M | -12.45M | -11.92M | -7.06M |
| Net Income | -12.74M | -11.15M | -11.77M | -11.99M | -8.66M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 27.95M | 25.8M | 31.79M | 21.58M | 18.25M |
| Total Liabilities | 18.24M | 21.67M | 13.12M | 13.93M | 7.85M |
| Total Equity | 9.71M | 4.13M | 18.66M | 7.65M | 10.41M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -10.27M | -10.68M | -11.88M | -10.15M | -7.9M |
| Investing | -240k | -607k | -2.49M | -1.93M | 887k |
| Financing | 17.18M | 9.48M | 21.14M | -135k | 9.91M |
| Market Cap | 15.07M |
| Price to Earnings Ratio | -1.74 |
| Price to Sales Ratio | 2.05 |
| Price to Cash Ratio | 1.29 |
| Price to Book Ratio | 1.45 |
| Dividend Yield | - |
| Shares Outstanding | 18.14M |
| Average Volume (1 week) | 24.45k |
| Average Volume (1 Month) | 25.79k |
| 52 Week Change | -61.79% |
| 52 Week High | 2.18 |
| 52 Week Low | 0.432 |
| Spread (Intraday) | 0 (0.12%) |
| Company Name | Global Bioenergies |
| Address |
5 rue henri desbrueres evry, essonne 91000 |
| Website | https://www.global-bioenergies.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
